This review suggests that specific biomarkers—such as angiopoietin-like protein 4, angiopoietin-like protein 8, lipocalin-2, CTRP-3, CTRP-9, apelin, and galectin-3—show a strong correlation with these complications in individuals with MetS. The gene discussed is C1QTNF9; the disease is metabolic syndrome.